Carmen Augustine

Jefferies and Citigroup initiated coverage for NuCana PLC (ADR) (NASDAQ: NCNA) Monday with a Buy rating and a price target of $25 and $23 respectively. Jefferies' analysts Eun Yang and Carmen Augustine explained that the company is focused on developing safer and more potent chemotherapies for...

In a report issued Monday, Jefferies analysts Eun K. Yang and Carmen Augustine looked into short interest in the biotech industry. According to the note, as of December 15, 2015, levels of weighted-average short interest remained unchanged for large-cap (more than $10 billion in market cap) and...